Infectious Diseases, Infection Control, and Employee Health

Medicine & Life Sciences

1. Infections 100%
2. Neoplasms 78%
3. Hematologic Neoplasms 49%
4. Catheters 47%
5. Aspergillosis 46%
6. Fungi 41%
7. Mucormycosis 40%
8. Invasive Fungal Infections 40%
9. Bacteremia 39%
10. Aspergillus 39%
11. Transplant Recipients 38%
12. Transplants 37%
13. Therapeutics 36%
14. Mycoses 35%
15. Catheter-Related Infections 34%
16. Candida 33%
17. Central Venous Catheters 30%
18. Aspergillus fumigatus 30%
19. Anti-Bacterial Agents 29%
20. Immunocompromised Host 29%
21. In Vitro Techniques 29%
22. Mortality 26%
23. posaconazole 25%
24. Virulence 24%
25. Neutropenia 24%
26. Amphotericin B 24%
27. Fever 23%
28. Caspofungin 22%
29. Cytomegalovirus 21%
30. Minocycline 21%
31. Vancomycin 21%
32. Voriconazole 21%
33. Streptococcus 21%
34. Pneumonia 20%
35. Diarrhea 19%
36. Invasive Pulmonary Aspergillosis 19%
37. Virus Diseases 19%
38. Hematopoietic Stem Cell Transplantation 18%
39. Anti-Infective Agents 18%
40. Biofilms 18%
41. Mucorales 18%
42. Fluconazole 17%
43. Candidemia 17%
44. Triazoles 17%
45. Leukemia 17%
46. Lung 16%
47. Cell Transplantation 16%
48. Azoles 16%
49. Allogeneic Cells 16%
50. Rhizopus 15%
51. Hepacivirus 15%
52. Communicable Diseases 15%
53. Echinocandins 15%
54. Vancomycin-Resistant Enterococci 15%
55. Cytomegalovirus Infections 14%
56. liposomal amphotericin B 14%
57. Quinolones 14%
58. Coronavirus 13%
59. Antiviral Agents 13%
60. Respiratory Tract Infections 13%
61. Ciprofloxacin 13%
62. Candida albicans 13%
63. Pseudomonas aeruginosa 13%
64. Escherichia coli 13%
65. Epidemiology 13%
66. Rifampin 12%
67. Safety 12%
68. Staphylococcus 12%
69. Antifungal Agents 12%
70. Fusariosis 12%
71. Acute Myeloid Leukemia 12%
72. Zygomycosis 12%
73. Staphylococcus aureus 12%
74. Pharmaceutical Preparations 12%
75. Respiratory Syncytial Viruses 11%
76. Daptomycin 11%
77. Methicillin-Resistant Staphylococcus aureus 11%
78. Blood Culture 11%
79. Fungemia 11%
80. Itraconazole 11%
81. Hematopoietic Stem Cells 11%
82. isavuconazole 11%
83. Bone Marrow 11%
84. Coagulase 11%
85. Linezolid 10%
86. Stem Cells 10%
87. Diptera 10%
88. Mexico 10%
89. Drug Therapy 10%
90. Genes 10%
91. Skin 10%
92. Respiratory Syncytial Virus Infections 9%
93. T-Lymphocytes 9%
94. Guidelines 9%
95. Vascular Access Devices 9%
96. Oryza 9%
97. Morbidity 9%
98. Stenotrophomonas maltophilia 9%
99. Infection Control 9%
100. Opportunistic Infections 9%